Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.
BACKGROUND: Adding insulin to oral therapy in type 2 diabetes mellitus is customary when glycemic control is suboptimal, though evidence supporting specific insulin regimens is limited. METHODS: In an open-label, controlled, multicenter trial, we randomly assigned 708 patients with a suboptimal gly...
Main Authors: | Holman, R, Thorne, K, Farmer, A, Davies, M, Keenan, J, Paul, S, Levy, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Differences in insulin treatment satisfaction following randomized addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes.
by: Farmer, A, et al.
Published: (2011) -
A practical guide to basal and prandial insulin therapy.
by: Holman, R, et al.
Published: (1985) -
Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
by: Rachman, J, et al.
Published: (1996) -
Addition of insulin to oral therapy in type 2 diabetes - Reply
by: Holman, R, et al.
Published: (2008) -
Characteristics of patients needing basal insulin to be given twice-daily or a second insulin formulation during the first year of the 4-T Trial
by: Levy, J, et al.
Published: (2008)